# FDA Inspection 791703 - Mylan Pharmaceuticals ULC - July 11, 2012

Source: https://www.keypedia.com/records/fda_inspections/mylan-pharmaceuticals-ulc/3e27cdec-9f2c-42a5-8d61-cde56ffac100
Source feed: FDA_Inspections

> FDA Inspection 791703 for Mylan Pharmaceuticals ULC on July 11, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 791703
- Company Name: Mylan Pharmaceuticals ULC
- Inspection Date: 2012-07-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 903842 - 2014-10-31](https://www.keypedia.com/records/fda_inspections/mylan-pharmaceuticals-ulc/2d648c34-dbe5-4781-9451-ac3b4a33e374)
- [FDA Inspection 571920 - 2009-02-26](https://www.keypedia.com/records/fda_inspections/mylan-pharmaceuticals-ulc/c84771b0-12da-49c1-8108-810fa123c623)

Company: https://www.keypedia.com/companies/mylan-pharmaceuticals-ulc/fb564bb2-650f-451b-8240-c86f4156f13a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c